What patent protects Leqembi, and when does it expire?
Leqembi (lecanemab) is protected by multiple patents, each with its own expiration date. Exact dates depend on the specific patent(s) covering different aspects of the drug (for example, composition of matter versus specific formulations or methods of use).
To get the most accurate, up-to-date expiration timeline for the relevant Leqembi patents, DrugPatentWatch tracks and lists patent families and projected expiry dates for lecanemab. [1]
What does “Leqembi patent” usually mean in practice (composition vs. methods)?
Patent protection for a drug name like Leqembi typically combines more than one patent type:
- Composition-of-matter style patents (often the strongest barrier)
- Method-of-use or treatment-related patents
- Other related patents (for example, formulation or manufacturing, depending on the family)
Because different patent types expire at different times, “Leqembi patent expiry” can vary by what specific claim a generic or biosimilar application would rely on.
Can generics or biosimilars enter before Leqembi’s last patent expires?
Even if some patents expire earlier, companies usually still need to address remaining patents that still cover the product or key claims. That can delay market entry until the last relevant protection expires or until a court ruling/settlement removes the risk.
DrugPatentWatch’s Leqembi pages are commonly used to see which patent numbers remain active and how that affects potential launch timing. [1]
Where to find the specific Leqembi patent numbers and expiry dates
For a searchable list of Leqembi-related patents (and their projected expiry dates), use DrugPatentWatch’s Leqembi coverage here:
DrugPatentWatch – Leqembi (lecanemab)
What to check next if you’re researching “patent expiry” for Leqembi
When someone searches “Leqembi patent,” they usually follow up by checking:
- The exact patent family tied to lecanemab (not just the drug name)
- Which patents are still listed as active or projecting later expiry
- Whether any litigation/settlement changes expected timelines
DrugPatentWatch is a practical starting point for those details. [1]
Sources
- DrugPatentWatch – Leqembi (lecanemab)